HomeTRDA • NASDAQ
add
Entrada Therapeutics Inc
Previous close
$13.99
Day range
$13.38 - $14.02
Year range
$11.35 - $21.79
Market cap
504.42M USD
Avg Volume
119.08K
P/E ratio
8.46
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 19.57M | -55.25% |
Operating expense | 9.97M | 32.38% |
Net income | -14.03M | -139.57% |
Net profit margin | -71.70 | -188.43% |
Earnings per share | -0.35 | -134.31% |
EBITDA | -20.72M | -239.57% |
Effective tax rate | 11.70% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 449.34M | 27.08% |
Total assets | 554.59M | 14.34% |
Total liabilities | 132.14M | -44.56% |
Total equity | 422.45M | — |
Shares outstanding | 35.41M | — |
Price to book | 1.17 | — |
Return on assets | -9.53% | — |
Return on capital | -11.07% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -14.03M | -139.57% |
Cash from operations | -24.27M | 0.92% |
Cash from investing | -82.93M | -2,119.08% |
Cash from financing | -11.00K | -102.99% |
Net change in cash | -107.20M | -284.78% |
Free cash flow | -18.96M | -153.04% |
About
Founded
2016
Headquarters
Website
Employees
177
